febuxostat has been researched along with ticagrelor in 1 studies
| Studies (febuxostat) | Trials (febuxostat) | Recent Studies (post-2010) (febuxostat) | Studies (ticagrelor) | Trials (ticagrelor) | Recent Studies (post-2010) (ticagrelor) |
|---|---|---|---|---|---|
| 818 | 133 | 710 | 2,425 | 594 | 2,246 |
| Protein | Taxonomy | febuxostat (IC50) | ticagrelor (IC50) |
|---|---|---|---|
| P2Y purinoceptor 13 | Homo sapiens (human) | 1.398 | |
| P2Y purinoceptor 12 | Homo sapiens (human) | 1.1028 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, Z; Dai, X; Duan, Y; Feng, Y; Gao, J; Lei, Y; Lin, F; Liu, D; Mao, Q; Mou, Y; Wang, S; Yang, Y; Zhang, B; Zhang, Y; Zhao, J | 1 |
1 other study(ies) available for febuxostat and ticagrelor
| Article | Year |
|---|---|
Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y
Topics: Animals; Binding Sites; Cytochrome P-450 Enzyme System; Drug Stability; Enzyme Inhibitors; Half-Life; Humans; Imidazoles; Mice; Microsomes, Liver; Molecular Docking Simulation; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Rats; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Structure-Activity Relationship; Ticagrelor; Xanthine Oxidase | 2020 |